Cyril Salek, MD
Institute of Hematology and Blood Transfusion, Czech Republic
2
2
1
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Suning Chen, M.D., Ph.D.
First Affiliated Hospital of Suzhou Medical College
Shared therapeutic areas:
Weili Zhao, M.D., Ph.D.
Shanghai Jiaotong University School of Medicine Ruijin Hospital
Shared therapeutic areas:
Elias Jabbour, M.D.
M.D. Anderson Cancer Center
Shared therapeutic areas:
Rachel B. Salit
Fred Hutch/University of Washington Cancer Consortium
Shared therapeutic areas:
Monica M Rivera Franco, M.D.,MSc
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Shared therapeutic areas:
Jianping Weng, Doctor
Third Affiliated Hospital, Sun Yat-Sen University
Shared therapeutic areas:
Isolda Fernández, Dr.
Grupo Argentino de Tratamiento de la Leucemia Aguda
Shared therapeutic areas:
Allen Yeoh, M.D
National University Hospital, Singapore
Shared therapeutic areas:
Prof Paul DiSilvestro, MD
Women & Infants Hospital, Providence, Rhode Island, USA
Shared therapeutic areas:
Jianxiang Wang, Dr
Institute of Hematology & Blood Diseases Hospital, China
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL
Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL)
All 2 trials loaded